A New Remedy For ImpotenceBy
Zonagen (ZONA) is a stock you wish you had stumbled upon earlier this year, when it was trading at 13. It has since scooted up to 33, thanks to its anti-impotence pill, which recently completed its third round of human trials.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.